Literature DB >> 25401415

Impact of procedure on the post-operative infection risk of patients after elective colon surgery.

David N Blitzer1, John M Davis, Nasim Ahmed, Yen-Hong Kuo, Yen-Liang Kuo.   

Abstract

BACKGROUND: Post-operative infection impacts the quality of patient care, prolongs the length of hospital stay, and utilizes more health care resources. The purpose of this study was to compare the rates of surgical site infection among three major surgical procedures for treating patients with colon pathology. HYPOTHESIS: The location of colon resection impacts the post-operative infection rate.
METHODS: A retrospective cohort study was conducted by using the 2006 Nationwide Inpatient Sample. Adult patients (age ≥18 yr) with colon diseases are the population of interest. The disease status and procedures were categorized according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Patients with a primary diagnosis of diverticulosis of the colon without hemorrhage (ICD-9-CM codes: 562.11 and 562.12) or malignant neoplasm of the colon (ICD-9-CM codes: 153.x, where x represents the possible digits within this ICD-9-CM code category), with procedures of open and other right hemicolectomy (ORH; ICD-9-CM code: 45.73) or open and other left hemicolectomy (OLH; ICD-9-CM code: 45.75), or open and other sigmoidectomy (OS; ICD-9-CM code: 45.76) were included for this study. The primary measured outcome for the study was surgical site infection.
RESULTS: There were an estimated 26,381 ORH procedures, 9,558 OLH procedures, and 31,656 OS procedures performed in 2006. There was a significant difference among procedures with respect to their age distributions (mean [standard error]: ORH vs. OLH vs. OS=70.5 [0.2] vs. 63.8 [0.3] vs. 59.5 [0.2] yr, p<0.0001) and the gender distributions (female percentage ORH vs. OLH vs. OS=56.1% vs. 51.5% vs. 50.9%, p<0.0001). There was a significant difference among the surgical procedures (infection rates: ORH vs. OLH vs. OS=2.9% vs. 5.6% vs. 4.9%, p<0.0001). From a logistic regression model, after controlling for age, gender, primary diagnosis, comorbidities, and hospital teaching status, OLH had a higher chance of SSI (adjusted odds ratio [AOR] [95% confidence interval {CI}]=1.54 [1.16-2,05], p=0.003) compared with ORH. However, OS did not have different SSI rates (AOR [95% CI]=1.18 [0.90-1.54], p=0.234) compared with ORH. There was a higher rate of infection for OLH (AOR [95% CI]: 1.31 [1.04-1.64], p=0.02) compared with OS.
CONCLUSIONS: Different sites of colon operations were associated with different risks of surgical site infections. Accordingly, appropriate pre-operative measures should address these differences.

Entities:  

Mesh:

Year:  2014        PMID: 25401415     DOI: 10.1089/sur.2013.147

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  3 in total

1.  Immunosuppressive medication is not associated with surgical site infection after surgery for intractable ulcerative colitis in children.

Authors:  Keiichi Uchida; Yoshikazu Ohtsuka; Atsushi Yoden; Hitoshi Tajiri; Hideaki Kimura; Takashi Isihige; Hiroyuki Yamada; Katsuhiro Arai; Takeshi Tomomasa; Kosuke Ushijima; Tomoki Aomatsu; Satoru Nagata; Kohei Otake; Kohei Matsushita; Mikihiro Inoue; Takahiro Kudo; Kenji Hosoi; Kazuo Takeuchi; Toshiaki Shimizu
Journal:  Intractable Rare Dis Res       Date:  2017-05

2.  Association of the Addition of Oral Antibiotics to Mechanical Bowel Preparation for Left Colon and Rectal Cancer Resections With Reduction of Surgical Site Infections.

Authors:  Elaine Vo; Nader N Massarweh; Christy Y Chai; Hop S Tran Cao; Nader Zamani; Sherry Abraham; Kafayat Adigun; Samir S Awad
Journal:  JAMA Surg       Date:  2018-02-01       Impact factor: 14.766

3.  Preoperative mechanical bowel preparation with oral antibiotics reduces surgical site infection after elective colorectal surgery for malignancies: results of a propensity matching analysis.

Authors:  Purun Lei; Ying Ruan; Xiaofeng Yang; Juekun Wu; Yujie Hou; Hongbo Wei; Tufeng Chen
Journal:  World J Surg Oncol       Date:  2020-02-11       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.